75% off all plans

Cryptococcosis

On this page

Organism & Virulence - Crypto's ID & Arsenal

  • Organism: Cryptococcus neoformans (common, esp. AIDS) & C. gattii (tropics, immunocompetent/compromised).
    • Encapsulated yeast, 5-10 µm diameter.
    • Round to oval, reproduces by narrow-based budding.
    • Not dimorphic (yeast form only).
    • Cryptococcus neoformans with India ink stain
  • Virulence Factors (Crypto's Arsenal):
    • Polysaccharide Capsule: Major! Mainly GXM (glucuronoxylomannan).
      • Antiphagocytic, inhibits leukocyte migration, immunosuppressive.

      ⭐ The capsule is its primary virulence factor; visualized by India Ink (negative stain) as a clear halo.

    • Melanin Production: Via laccase.
      • Protects from oxidative stress & host enzymes; neurotropic. (📌 "MELANIN: Mighty & Mind-loving")
    • Phospholipase B: Host membrane damage, tissue invasion.
    • Urease: Produces $NH_3$, ↑pH, aids CNS invasion (BBB).
    • Thermotolerance: Grows at 37°C.

Epidemiology & Risk Factors - Who Gets Hit & How

  • Distribution & Species:
    • C. neoformans: Ubiquitous worldwide.
    • C. gattii: Predominantly tropical/subtropical; emerging temperate (Pacific NW).
  • Reservoirs:
    • C. neoformans: Soil enriched with pigeon guano.
    • C. gattii: Eucalyptus trees, decaying wood.
  • Transmission: Inhalation of airborne yeast/basidiospores. No human-to-human spread.
  • Risk Factors (C. neoformans):
    • Cellular Immunodeficiency (Major):
      • HIV/AIDS: CD4+ T-cell count < 100 cells/µL (most critical). 📌 AIDS-defining illness.
      • Solid organ transplant recipients (on immunosuppressive therapy).
      • Prolonged high-dose corticosteroid therapy.
      • Hematologic malignancies (e.g., lymphoma, CLL).
      • Sarcoidosis.
      • Biologic agents (e.g., TNF-α inhibitors).
    • C. gattii: Notably can infect immunocompetent individuals, unlike typical C. neoformans.

⭐ Globally, cryptococcal meningitis is a leading opportunistic infection and a major cause of mortality in patients with advanced HIV/AIDS.

Clinical Manifestations - Brain & Lung Invasion

  • Pulmonary Cryptococcosis:

    • Often asymptomatic in immunocompetent individuals.
    • Symptoms: Cough (productive or non-productive), low-grade fever, pleuritic chest pain, dyspnea, weight loss.
    • Radiology: Nodules (cryptococcomas), infiltrates (diffuse or lobar), pleural effusions, hilar lymphadenopathy.
    • Can disseminate, especially in immunocompromised.
  • Cryptococcal Meningoencephalitis (CM): Most common CNS manifestation.

    • Predominantly in immunocompromised (HIV/AIDS, CD4 < 100 cells/µL).
    • Symptoms: Headache (often severe, persistent), fever, altered mental status, lethargy, nausea, vomiting, neck stiffness, photophobia, seizures.
    • Cranial nerve palsies (esp. VI, VII, VIII) common.
    • ↑ Intracranial pressure (ICP) is a major cause of morbidity/mortality.

      ⭐ Raised ICP is a hallmark of cryptococcal meningitis and a poor prognostic indicator. Management often requires therapeutic lumbar punctures or shunting.

image

  • Other sites of dissemination (less common): Skin (papules, pustules, ulcers resembling molluscum contagiosum), bone, prostate, eyes (choroidoretinitis).

Diagnosis & Management - Unmasking & Eradicating

  • Diagnosis:
    • CSF analysis: ↑Protein, ↓Glucose, Lymphocytic pleocytosis.
    • India Ink: Encapsulated budding yeast (halos). Sensitivity ~50-80% in AIDS.
      • India ink stain of Cryptococcus neoformans in CSF
    • Cryptococcal Antigen (CrAg): Serum/CSF. Rapid, high Sensitivity & Specificity.

      ⭐ CrAg titers often correlate with fungal burden and can monitor therapeutic response.

    • Culture (SDA): Gold standard.
  • Management:
    • Manage ↑Intracranial Pressure (ICP): Aggressive! Therapeutic Lumbar Punctures (if Opening Pressure >25 $cm H_2O$); shunts if refractory.
    • Antifungal Therapy (Phased for CNS disease):
-   Induction (HIV+ or severe CNS): Liposomal Ampho B (LAmB) **3-4** mg/kg/d IV + Flucytosine (5-FC) **100** mg/kg/d PO (div. doses) x ≥**2** wks.
-   Consolidation: Fluconazole **400-800** mg/d PO x **8** wks.
-   Maintenance: Fluconazole **200** mg/d PO x ≥**1** yr.
-   Immune Reconstitution Inflammatory Syndrome (IRIS): Paradoxical worsening on ART; manage with NSAIDs/steroids if severe.

High‑Yield Points - ⚡ Biggest Takeaways

  • Cryptococcus neoformans: Encapsulated yeast from pigeon droppings; acquired by inhalation.
  • Key virulence: Large polysaccharide capsule (visualized by India Ink, resists phagocytosis).
  • High risk: HIV/AIDS patients (CD4 < 100 cells/µL), other immunocompromised states.
  • Predominant disease: Meningoencephalitis; also causes pulmonary and cutaneous infections.
  • Diagnosis: Cryptococcal antigen (CrAg) test (CSF/serum) is crucial; CSF India Ink for direct visualization.
  • Treatment: Amphotericin B + Flucytosine for induction, followed by Fluconazole maintenance.

Continue reading on OnCourse

Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.

CONTINUE READING — FREE

or get the app

Rezzy AI Tutor

Have doubts about this lesson?

Ask Rezzy, our AI tutor, to explain anything you didn't understand

Practice Questions: Cryptococcosis

Test your understanding with these related questions

Which of the following is NOT a virulence factor of Cryptococcus?

1 of 5

Flashcards: Cryptococcosis

1/10

_____ agar is used to demonstrate melanin production by Cryptococcus neoformans

TAP TO REVEAL ANSWER

_____ agar is used to demonstrate melanin production by Cryptococcus neoformans

Niger seed

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

START FOR FREE